<?xml version="1.0" encoding="UTF-8"?>
<ref id="b12-1031308">
 <label>12.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Uy</surname>
    <given-names>GL</given-names>
   </name>
   <name>
    <surname>Rettig</surname>
    <given-names>MP</given-names>
   </name>
   <name>
    <surname>Motabi</surname>
    <given-names>IH</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia</article-title>. 
  <source>Blood</source>. 
  <year>2012</year>;
  <volume>119</volume>(
  <issue>17</issue>):
  <fpage>3917</fpage>â€“
  <lpage>3924</lpage>.
  <pub-id pub-id-type="pmid">22308295</pub-id>
 </mixed-citation>
</ref>
